XNAS · MDGL
-0.95% · -$5.39 · Vol 379.0K
Market closed · last close 4:00 PM ET · price as of 16:29:20 ET
Madrigal Pharmaceuticals, Inc. Common Stock

Madrigal Pharmaceuticals, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$560.01
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is MDGL moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for MDGL are being assembled.
About Madrigal Pharmaceuticals, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2007
Employees
915
Country
US

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$564.87
Day high
$569.44
Day low
$548.36
Previous close
$565.40
52W high
$569.44
-1.66% from high
52W low
$471.32
90% of range
Market cap
$13B
EPS
$-13.5500
Shares out
23.1M
Volume
379K
VWAP
$558.19
Price history computed in-house
1W
+4.31%
1M
+17.27%
SMA 50 $515.65 · above
SMA 200 $515.65 · above
52W position 90%
Veridion warehouse edge

Warehouse intelligence for MDGL.

Veridion Score
57
0: 221: 402: 553: 704: 775: 60
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

MDGL insider activity

Madrigal Pharmaceuticals, Inc. Common Stock

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for MDGL.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

MDGL contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MDGL in this window.
Lobbying spend

MDGL lobbying filings, year to date.

Registered lobbying filings matched to Madrigal Pharmaceuticals, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for MDGL in this window.
Latest news · MDGL
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for MDGL.
Options
Sovereign unlock shows live options positioning for MDGL.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.